CN103713080A - Method for detecting content of gamithromycin - Google Patents

Method for detecting content of gamithromycin Download PDF

Info

Publication number
CN103713080A
CN103713080A CN201310745236.3A CN201310745236A CN103713080A CN 103713080 A CN103713080 A CN 103713080A CN 201310745236 A CN201310745236 A CN 201310745236A CN 103713080 A CN103713080 A CN 103713080A
Authority
CN
China
Prior art keywords
adds
mycin
content
meter
meter mycin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201310745236.3A
Other languages
Chinese (zh)
Inventor
姜淋洁
王猛
程雪娇
余贵菊
焦晓军
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Challenge (tianjin) Animal Pharmaceutical Co Ltd
Original Assignee
Challenge (tianjin) Animal Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Challenge (tianjin) Animal Pharmaceutical Co Ltd filed Critical Challenge (tianjin) Animal Pharmaceutical Co Ltd
Priority to CN201310745236.3A priority Critical patent/CN103713080A/en
Publication of CN103713080A publication Critical patent/CN103713080A/en
Pending legal-status Critical Current

Links

Images

Landscapes

  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)

Abstract

The invention provides a method for detecting the content of gamithromycin. The method comprises the steps: dissolving a gamithromycin sample to be detected by a flowing phase, and performing liquid phase chromatogram quantitative analysis by using a DAD (Dioxide Array Detector) detector adopting C8 and C18 chromatographic columns, wherein chromatographic conditions are as follows: the flowing phase is as follows: a weight ratio of acetonitrile to 0.025mol/ml dipotassium phosphate solution (PH8-8.5) is 70:30, a flow velocity is 1.00-2.00ml/min, and a detection wavelength is 210-230nm. The method is accurate and simple, and is good in reproducibility and high in sensitivity.

Description

A kind of detection method of content that adds meter mycin
Technical field
The present invention relates to a kind of medicament contg detection method, especially a kind of detection method of content that adds meter mycin.
Background technology
Add a meter mycin (Gamithromycin) and belong to macrolide antibiotics, be mainly used in treating the cattle infected disease that the bacterial pathogens such as pasteurella haemolytica, pasteurella multocida and Histophilus cause, have and absorb the advantages such as fast, the interior widely distributed residual quantity of body is low, security is high, and the report that has no adverse reaction temporarily has wide practical use on veterinary clinic.
The synthetic route that adds meter mycin is as follows:
Figure BDA0000446236320000011
Yet in exploitation, add in the process of meter mycin, this chemicals does not have ready-made determination and analysis method, and this present situation makes this medicine there is no unified standard, has hindered greatly application and the popularization of this medicine.Therefore it is very necessary, setting up a set of effective, stable detection method of content.
Summary of the invention
Technical matters to be solved by this invention is to provide a kind of detection method of content that adds meter mycin.
For solving the problems of the technologies described above, technical scheme of the present invention is:
A kind of detection method of content that adds meter mycin, adopt liquid chromatography to analyze, concrete steps are: mobile phase dissolves meter mycin sample that adds to be detected, take C8, C18 as chromatographic column, with DAD detecting device, carry out chromatogram quantitative analysis of the liquid phase, its chromatographic condition is: mobile phase: acetonitrile: 0.025mol/ml dipotassium hydrogen phosphate solution (PH8-8.5)=70:30, flow velocity: 1.00-2.00ml/min, detects wavelength: 210-230nm.
Preferably, the above-mentioned detection method of content that adds meter mycin, described mobile phase dissolves to be detected adding after meter mycin sample, and adding a meter mycin sample concentration is 0.006mg/ml-1.523mg/ml.
Preferably, the above-mentioned detection method of content that adds meter mycin, described chromatographic condition is: mobile phase: acetonitrile: 0.025mol/ml dipotassium hydrogen phosphate solution (PH8.2)=70:30, flow velocity: 1.00ml/min, detects wavelength: 210nm.
Preferably, the above-mentioned detection method of content that adds meter mycin, is added the mould cellulose content of rice and carries out quantitatively adding by external standard method in meter mycin sample.
The invention has the beneficial effects as follows:
The above-mentioned detection method of content that adds meter mycin, by liquid chromatography, carry out analyzing and testing, external standard method is carried out quantitatively adding the mould cellulose content of rice in sample, described method is accurate, simple, favorable reproducibility, highly sensitive, when adding meter mycin between 0.004mg/ml-1.2mg/ml time, all have good linear relationship, its linearly dependent coefficient is 0.9997.
Accompanying drawing explanation
Fig. 1 adds a meter liquid chromatogram for mycin reference substance;
Fig. 2 is the liquid chromatogram that adds meter mycin;
Fig. 3 adds a meter liquid chromatogram for mycin parenteral solution;
Fig. 4 adds a meter liquid chromatogram for mycin soluble powder.
Embodiment
In order to make those skilled in the art better understand technical scheme of the present invention, below in conjunction with embodiment, technical scheme of the present invention is described in further detail.
Embodiment 1
I instrument and equipment and starting material:
Agilent 1260 chromatographic analyzer of liquid phase, are equipped with DAD diode array detector, OPENLAB chromatographic work station, C 8, C 18chromatographic column;
Acetonitrile (HPLC level), dipotassium hydrogen phosphate (AG), secondary deionized water, add a meter mycin reference substance (being provided by Nat'l Pharmaceutical & Biological Products Control Institute), add a meter mycin (commercially available).
II adds a meter preparation for mycin analytic sample:
1, take 0.01021g and add meter mycin to 10ml volumetric flask, add 2ml acetonitrile and dissolve, with mobile phase, be diluted to scale, shake up.
2, precision takes and adds in meter mycin reference substance 10.02 ㎎ to 10ml volumetric flasks, adds 2ml acetonitrile and dissolves, and with mobile phase, is diluted to scale, shakes up.
3, chromatographiccondition:
Mobile phase: acetonitrile: 0.025mol/ml dipotassium hydrogen phosphate solution (PH8.2)=70:30;
Flow velocity: 1.00ml/min;
Detect wavelength: 210nm;
Sample size: 20 μ l.
4, by external standard method, calculate and add meter content of mycin sample a: a=A samplem mark/ A markm sample* 100%=10.02*1363.6/1390.6*10.21*100%=96.2% (the results are shown in Figure 1 and Fig. 2)
Embodiment 2
I instrument and equipment and starting material:
Agilent 1260 chromatographic analyzer of liquid phase, are equipped with DAD diode array detector, OPENLAB chromatographic work station, C 8, C 18chromatographic column;
Acetonitrile (HPLC level), dipotassium hydrogen phosphate (AG), secondary deionized water, add a meter mycin reference substance (being provided by Nat'l Pharmaceutical & Biological Products Control Institute), add a meter mycin parenteral solution (commercially available, specification 15g:100ml).
II adds a meter preparation for mycin analytic sample:
1, pipette 1ml and add meter mycin parenteral solution to 10ml volumetric flask, with mobile phase, be diluted to scale, shake up; With appropriate mobile phase dilute solution to 1 ㎎/ml progressively, with filtering with microporous membrane gained solution.
2, precision takes and adds in meter mycin reference substance 10.15 ㎎ to 10ml volumetric flasks, adds 1-2ml acetonitrile and dissolves, and with mobile phase, is diluted to scale, shakes up, with filtering with microporous membrane gained solution.
3, chromatographiccondition:
Mobile phase: acetonitrile: 0.025mol/ml dipotassium hydrogen phosphate solution (PH8.2)=70:30;
Flow velocity: 1.00ml/min;
Detect wavelength: 210nm;
Sample size: 20 μ l.
4, by external standard method, calculate and add a meter content for mycin parenteral solution.A=A samplem mark/ 1500A mark* 100%=1370.3*10.15/10*1390.6*100%=100.02%(the results are shown in Figure 1 and Fig. 3)
Embodiment 3
I instrument and equipment and starting material:
Agilent 1260 chromatographic analyzer of liquid phase, are equipped with DAD diode array detector, OPENLAB chromatographic work station, C 8, C 18chromatographic column;
Acetonitrile (HPLC level), dipotassium hydrogen phosphate (AG), secondary deionized water, add a meter mycin reference substance (being provided by Nat'l Pharmaceutical & Biological Products Control Institute), add a meter mycin pre-mixing agent (commercially available, specification 15g:100g).
II adds a meter preparation for mycin analytic sample:
1, pipette 1.04g and add meter mycin pre-mixing agent to 10ml volumetric flask, with mobile phase, be diluted to scale, shake up, with appropriate mobile phase dilute solution to 1 ㎎/ml progressively, with filtering with microporous membrane gained solution.
2, precision takes and adds in meter mycin reference substance 10.11 ㎎ to 10ml volumetric flasks, adds 1-2ml acetonitrile and dissolves, and with mobile phase, is diluted to scale, shakes up, with filtering with microporous membrane gained solution.
3, chromatographiccondition:
Mobile phase: acetonitrile: 0.025mol/ml dipotassium hydrogen phosphate solution (PH8.2)=70:30;
Flow velocity: 1.00ml/min;
Detect wavelength: 210nm;
Sample size: 20 μ l.
4, by external standard method, calculate and add a meter content for mycin parenteral solution.A=A samplem mark/ 10.4A mark* 100%=1349.2*10.11/10.4*1390.6*100%=94.3%(the results are shown in Figure 1 and Fig. 4)
Above-mentioned detailed description of this kind of detection method of content that adds meter mycin being carried out with reference to embodiment; illustrative rather than determinate; can list several embodiment according to institute's limited range; therefore in the variation and the modification that do not depart under general plotting of the present invention, within should belonging to protection scope of the present invention.

Claims (4)

1. a detection method of content that adds meter mycin, it is characterized in that: adopt liquid chromatography to analyze, concrete steps are: mobile phase dissolves meter mycin sample that adds to be detected, take C8, C18 as chromatographic column, with DAD detecting device, carry out chromatogram quantitative analysis of the liquid phase, its chromatographic condition is: mobile phase: acetonitrile: 0.025mol/ml dipotassium hydrogen phosphate solution (PH8-8.5)=70:30, flow velocity: 1.00-2.00ml/min, detects wavelength: 210-230nm.
2. the detection method of content that adds meter mycin according to claim 1, is characterized in that: described mobile phase dissolves to be detected adding after meter mycin sample, and adding a meter mycin sample concentration is 0.006mg/ml-1.523mg/ml.
3. the detection method of content that adds meter mycin according to claim 1, it is characterized in that: described chromatographic condition is: mobile phase: acetonitrile: 0.025mol/ml dipotassium hydrogen phosphate solution (PH8.2)=70:30, flow velocity: 1.00ml/min, detects wavelength: 210nm.
4. the detection method of content that adds meter mycin according to claim 1, is characterized in that: by external standard method, to adding, added the mould cellulose content of rice carry out quantitatively in meter mycin sample.
CN201310745236.3A 2013-12-25 2013-12-25 Method for detecting content of gamithromycin Pending CN103713080A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201310745236.3A CN103713080A (en) 2013-12-25 2013-12-25 Method for detecting content of gamithromycin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201310745236.3A CN103713080A (en) 2013-12-25 2013-12-25 Method for detecting content of gamithromycin

Publications (1)

Publication Number Publication Date
CN103713080A true CN103713080A (en) 2014-04-09

Family

ID=50406223

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201310745236.3A Pending CN103713080A (en) 2013-12-25 2013-12-25 Method for detecting content of gamithromycin

Country Status (1)

Country Link
CN (1) CN103713080A (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104535693A (en) * 2015-01-21 2015-04-22 天津市中升挑战生物科技有限公司 Content detection method of gamithromycin
CN107525875A (en) * 2017-09-15 2017-12-29 华北制药集团动物保健品有限责任公司 A kind of detection method of Gamithromycin about material
CN107632102A (en) * 2017-09-13 2018-01-26 华北制药集团动物保健品有限责任公司 A kind of detection method of Gamithromycin content
CN107764906A (en) * 2016-08-22 2018-03-06 洛阳惠中兽药有限公司 A kind of detection method of content of Gamithromycin
CN108567790A (en) * 2017-03-10 2018-09-25 洛阳惠中兽药有限公司 A kind of Gamithromycin pharmaceutical composition and its application
CN111778215A (en) * 2020-07-08 2020-10-16 江南大学 Hybridoma cell strain secreting gamithromycin monoclonal antibody and application thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1262686A (en) * 1997-07-08 2000-08-09 生物化学股份有限公司 Organic compound
CN1411465A (en) * 1999-12-20 2003-04-16 梅瑞尔公司 Method for preparing and isolating 9-deoxo-9 (Z)-hydroxyiminoerythromycin A
CN102239174A (en) * 2008-10-24 2011-11-09 梅里亚有限公司 Method of synthesizing macrolide compounds

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1262686A (en) * 1997-07-08 2000-08-09 生物化学股份有限公司 Organic compound
CN1411465A (en) * 1999-12-20 2003-04-16 梅瑞尔公司 Method for preparing and isolating 9-deoxo-9 (Z)-hydroxyiminoerythromycin A
CN102239174A (en) * 2008-10-24 2011-11-09 梅里亚有限公司 Method of synthesizing macrolide compounds

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
R. A. HUANG ET AL.: "Pharmacokinetics of gamithromycin in cattle with comparison of plasma and lung tissue concentrations and plasma antibacterial activity", 《J. VET. PHARMACOL. THERAP.》 *
容永欢: "高效液相色谱法测定阿奇霉素在其分散片中的含量", 《中南药学》 *
王建华 等: "一步法合成9-去氧-8a-氮杂-8a-同型红霉素A", 《合成化学》 *
薛红: "大环内酯类抗生素质量研究的几个重点", 《北方药学》 *

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104535693A (en) * 2015-01-21 2015-04-22 天津市中升挑战生物科技有限公司 Content detection method of gamithromycin
CN107764906A (en) * 2016-08-22 2018-03-06 洛阳惠中兽药有限公司 A kind of detection method of content of Gamithromycin
CN108567790A (en) * 2017-03-10 2018-09-25 洛阳惠中兽药有限公司 A kind of Gamithromycin pharmaceutical composition and its application
CN107632102A (en) * 2017-09-13 2018-01-26 华北制药集团动物保健品有限责任公司 A kind of detection method of Gamithromycin content
CN107525875A (en) * 2017-09-15 2017-12-29 华北制药集团动物保健品有限责任公司 A kind of detection method of Gamithromycin about material
CN111778215A (en) * 2020-07-08 2020-10-16 江南大学 Hybridoma cell strain secreting gamithromycin monoclonal antibody and application thereof
CN111778215B (en) * 2020-07-08 2021-11-12 江南大学 Hybridoma cell strain secreting gamithromycin monoclonal antibody and application thereof

Similar Documents

Publication Publication Date Title
CN103713080A (en) Method for detecting content of gamithromycin
CN104655751B (en) A kind of detect the method for organic solvent residual in dapoxetine
CN104991017B (en) Liquid chromatogram-tandem mass spectrometry method for determining isothiazolinone bactericides contained in water-based adhesive
CN102103128A (en) Method for determining contents of formaldehyde, acetaldehyde and acetone in water-borne adhesives for cigarettes
CN104483403B (en) A kind of detect the method that R-lansoprazole bulk drug has related substance
CN103592379A (en) Analytic method of omeprazole related substance
CN101876650A (en) Method for measuring formaldehyde content in smoke aqueous gel
CN103698424B (en) Detecting method of detecting organic solvent in slightly-soluble aluminum salt drug
CN102955010A (en) Quality detection method of traditional Chinese medicine callicarpa nudiflora preparation
CN104535693B (en) A kind of Gamithromycin detection method of content
CN103558318A (en) Determination method for detecting trace hydroxylamine hydrochloride in medicine
CN105424834B (en) Detect 2-Pyrrolidone and formic acid method in PVP K30 simultaneously
CN108398497B (en) High performance liquid chromatography detection method of tris (nonylphenol) phosphite ester
CN104198596A (en) Detection method of solvent residue in sodium propylthiouracil salt
CN104597157B (en) The assay method of a kind of liposoluble platinum complex and preparation related substance thereof
CN104634911B (en) A kind of 4 kinds of flavonoids effective constituent detection methods of CHUANKEZHI ZHUSHEYE
CN105467035A (en) Method for detecting macromolecular substances in Shenxiong glucose injection
CN103063794B (en) Content detecting and control method of epalrestat tablets
CN102565208A (en) Novel method for detecting etimicin sulfate
CN103995062B (en) Method for testing exenatide and impurities thereof by using high performance liquid chromatography
CN105572240A (en) Method for detecting content of pharmaceutic adjuvant carmine by using high performance liquid chromatography
CN102109499A (en) Method for simultaneously detecting acetone and ethyl acetate residues in drug by gas chromatography
CN103175930A (en) High performance liquid chromatography analysis method for measuring sodium sulfite content
CN105954431B (en) A kind of method of the HPLC separation determination Ao Pei meter Fen bulk pharmaceutical chemicals in relation to substance
CN112763585A (en) Method for determining benzene impurity content in sulfadiazine or sulfadiazine derivative

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20140409